H2AC7: A Potential Drug Target and Biomarker (G3013)
H2AC7: A Potential Drug Target and Biomarker
Hydrazoneurea (H2AC7) is a protein that is expressed in various tissues and cells in the body. Its function is not well understood, but it is known to play a role in the regulation of inflammation and cell growth. H2AC7 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The protein H2AC7 is composed of 78 amino acid residues and has a calculated molecular weight of 9.7 kDa. It is expressed in a variety of tissues, including the brain, heart, liver, and muscle. H2AC7 is involved in the regulation of cellular processes that are critical for maintaining tissue health and function.
One of the functions of H2AC7 is its role in the regulation of inflammation. Inflammation is a critical response of the immune system to harmful stimuli, but chronic inflammation can lead to a range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. H2AC7 has been shown to play a role in the regulation of inflammation by suppressing the production of pro-inflammatory cytokines.
H2AC7 has also been shown to play a role in the regulation of cell growth. Cell growth is a critical process that is essential for the development and maintenance of tissues and organs, but it can also be a source of cancer. H2AC7 has been shown to regulate cell growth by suppressing the production of S600, a transcription factor that promotes cell growth.
In addition to its functions in inflammation and cell growth, H2AC7 has also been shown to play a role in the regulation of cellular processes that are critical for maintaining tissue homeostasis. Tissue homeostasis refers to the ability of tissues to maintain a stable internal environment that is essential for proper cellular function. H2AC7 has been shown to regulate the production of various transcription factors that are involved in maintaining tissue homeostasis, including PPAR未, NF-kappa-B, and AP-1.
H2AC7 has also been shown to play a role in the regulation of cellular processes that are critical for the development and maintenance of tissues and organs. The development and maintenance of tissues and organs is a critical process that is essential for the survival of all living organisms. H2AC7 has been shown to regulate the production of transcription factors that are involved in the development and maintenance of tissues and organs, including transforming growth factor (TGF-2), bone marrow-derived factor (BMF), and angiogenesis.
In conclusion, H2AC7 is a protein that is involved in a variety of cellular processes that are critical for maintaining tissue health and function. Its functions in inflammation, cell growth, and tissue homeostasis have been well-documented, and it has been identified as a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of H2AC7 in these processes and to develop effective treatments for these diseases.
Protein Name: H2A Clustered Histone 7
Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling
The "H2AC7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H2AC7 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2
